Accumulating evidence indicates that dysregulation of the AMPK system is associated with metabolic disorders, metabolic syndrome, insulin resistance and also type 2 diabetes [10, 58, 75]. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.